The values of thetheta p p p p p p p p p p p p p p p p p p p p p p p p p p.)

摘要

The present invention relates to a drug used in the manufacturing process using a combination of anti-alpha-gamma-epsilon_-gamma-epsilon__kappa_factor and anti-_-epsilon-epsilon_a_factor. A related disease is treated with angiogenesis in a warm blooded mammal, such as humans.The invention also relates to a pharmaceutical composition comprising an antiangiogenic factor and an antihypertensive factor, the ladies in the kit I am in a way to treat diseases and angiogenesis.These include an effective quality management combination of anti-alpha-gamma-epsilon_-gamma-epsilon__kappa_factor and an anti-_-epsilon_-alpha__factor at one meeting Mammals such as human beings.